BRAF-V600E mutation in pediatric and adult glioblastoma

Neuro-Oncology

Volumn 16, Issue 2, 2014, Pages 318-319

  Dahiya, Sonika ^a   Emnett, Ryan J ^b   Haydon, Devon H ^a   Leonard, Jeffrey R ^a   Phillips, Joanna J ^a   Perry, Arie ^a   Gutmann, David H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

brain tumor; children; glioma; microarray

Indexed keywords

B RAF KINASE;

CANCER GRADING; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER;

BRAIN TUMOR; CHILDREN; GLIOMA; MICROARRAY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CHILD; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893145278     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not146     Document Type: Letter

References (16)

1. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739-1749.
2. Jacob K, Albrecht S, Sollier C, et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumors. Br J Cancer. 2009;101(4):722-733.
3. Yu J,DeshmukhH,GutmannRJ, et al. Alterations of BRAFand HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology. 2009; 73(19):1526-1531.
4. Schiffman JD, Hodgson JG, VandenBerg SR, et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 2010;70(2):512-519.
5. Dias-Santagata D, LamQ,VernovskyK, et al.BRAFV600Emutations are common in pleomorphic xanthoastrocytoma: Diagnostic and therapeutic implications. PLoS One. 2011;6(3):e17948.
6. Schindler G, Capper D, Meyer J, et al. Analysis of BRAFV600E mutation in 1320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extracerebellar pilocytic astrocytoma. Acta Neuropathol. 2011;121(3): 397-405.
7. Dougherty MJ, Santi M, Brose MS, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro- Oncol. 2010;12(7):621-630.
8. Chappe C, Padovani L, Scavarda D, et al. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAFV600E mutation and expression. Brain Pathol. 2013;23(5):574-583.
9. DahiyaS,HaydonDH, AlvaradoD, Gurnett CA,GutmannDH, LeonardJR. BRAFV600E is a negative prognostic in pediatric gangliogliomas. Acta Neuropathol. 2013;125(6):901-910.
10. Koelsche C, Sahm F, Paulus W, et al. BRAFV600E expression and distribution in desmoplastic infantile astrocytoma/gangliogliomas. Neuropathol Appl Neurobiol. 2013;126(6):907-915.
11. Chi AS, Batchelor TT, Yang D, et al. BRAFV600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults. J Clin Oncol. 2013;31(14):e233-e236.
12. Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK. Epithelioid GBMs show a high percentage of BRAFV600E mutation. Am J Surg Pathol. 2013;37(5):685-698.
13. Basto D, Trovisco V, Lopes JM, et al. Mutation analysis of BRAF gene in human gliomas. Acta Neuropathol. 2005;109(2): 207-210.
14. Tian Y, Rich BE, Vena N, et al. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas. J Mol Diagn. 2011(6):13:669-677.
15. Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphological and molecular genetic study. Cancer. 2008;113(10):2779-2789.
16. Nicolaides T, Li H, Solomon D, et al. Targeted therapy for BRAF V600E malignant astrocytoma. Clin Cancer Res. 2011;17(24): 7595-7604.